Hyundai Bioscience Co., Ltd. (KOSDAQ: 048410)

Hyundai Bioscience Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	8,057	1,812	2,732	9,189	19,215	5,555
Short-Term Investments	-	10,000	16,000	13,010	-	1,500
Cash & Short-Term Investments	8,057	11,812	18,732	22,199	19,215	7,055
Cash Growth	-39.88%	-36.94%	-15.62%	15.53%	172.36%	123.10%
Accounts Receivable	446.27	446.21	1,277	7,628	11,035	18,072
Other Receivables	1.54	19.54	50.97	55.15	2,414	664.35
Receivables	447.82	465.75	1,671	8,825	17,250	19,386
Inventory	424.52	2,588	2,946	3,350	4,215	6,080
Prepaid Expenses	116.63	204.45	568.66	337.92	195	466.39
Other Current Assets	27.86	92.36	93.33	138.65	985	281.58
Total Current Assets	9,074	15,163	24,012	34,851	41,860	33,269
Property, Plant & Equipment	2,641	2,904	6,376	6,073	6,674	7,196
Long-Term Investments	23,758	1,593	1,469	4,930	4,875	2,959
Other Intangible Assets	33,170	31,170	33,175	33,664	39,395	19,409
Other Long-Term Assets	1,352	914.36	1,268	929.34	877.22	856.36
Total Assets	70,968	52,792	67,327	80,528	93,741	64,220
Accounts Payable	448.59	430.52	686.72	191.61	178.17	827.76
Accrued Expenses	175.55	141.71	141.35	123.66	143.59	172.37
Short-Term Debt	25,173	5,400	5,900	14,014	6,400	11,606
Current Portion of Long-Term Debt	-	-	111.08	833.32	833.36	500
Current Portion of Leases	113.44	114.1	196.17	354.1	369.82	282.08
Other Current Liabilities	526.77	860.43	1,957	1,744	1,652	1,145
Total Current Liabilities	26,437	6,947	8,992	17,261	9,577	14,533
Long-Term Debt	-	-	-	111.08	29,112	1,000
Long-Term Leases	62.75	32.43	41.7	174.69	423.22	85.99
Long-Term Deferred Tax Liabilities	-	-	-	1,296	2,073	449.55
Other Long-Term Liabilities	541.56	541.56	57.23	57.23	15	15
Total Liabilities	27,228	7,521	9,091	18,957	41,403	16,463
Common Stock	19,911	19,905	19,841	19,330	17,958	17,323
Additional Paid-In Capital	39,797	38,827	145,476	133,406	104,930	93,682
Retained Earnings	-15,165	-12,812	-106,288	-90,481	-70,430	-62,170
Treasury Stock	-4.04	-4.04	-4.04	-4.04	-4.04	-4.04
Comprehensive Income & Other	-798.32	-645.72	-789.52	-680.57	-116.86	-1,073
Shareholders' Equity	43,740	45,271	58,235	61,571	52,338	47,758
Total Liabilities & Equity	70,968	52,792	67,327	80,528	93,741	64,220
Total Debt	25,349	5,547	6,249	15,488	37,138	13,474
Net Cash (Debt)	-17,292	6,265	12,483	6,712	-17,923	-6,419
Net Cash Growth	-	-49.81%	86.00%	-	-	-
Net Cash Per Share	-434.32	157.52	317.10	181.81	-499.06	-185.28
Filing Date Shares Outstanding	39.82	39.81	39.68	38.66	35.91	34.64
Total Common Shares Outstanding	39.82	39.81	39.68	38.66	35.91	34.64
Working Capital	-17,364	8,216	15,020	17,590	32,283	18,736
Book Value Per Share	1098.47	1137.24	1467.61	1592.73	1457.32	1378.55
Tangible Book Value	10,571	14,101	25,061	27,906	12,943	28,349
Tangible Book Value Per Share	265.46	354.23	631.56	721.89	360.39	818.31
Land	1,100	1,100	1,100	1,100	1,100	1,100
Buildings	3,834	3,834	5,190	5,190	5,190	5,190
Machinery	10,435	10,435	11,644	13,822	13,822	13,822
Construction In Progress	-	16	773.4	225	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.